Coralie Poulard
Lyon, 69000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
How post-translational modifications impact glucocorticoid receptor function in human pathologies.
Journal: Cell communication and signaling : CCS
Published: March 09, 2026
An ERRα-ZEB1 transcriptional signature predicts survival in triple-negative breast cancers.
Journal: Molecular medicine (Cambridge, Mass.)
Published: January 08, 2026
Targeting PRMTs Creates Vulnerability of DNA Double-Stand Break Repair Pathways, and Potentiates Chemotherapy Efficacy in TNBC.
Journal: Cancer science
Published: September 25, 2025
Targeting the JAK/STAT Signaling Pathway in Breast Cancer: Leaps and Hurdles.
Journal: Biomedicines
Published: July 22, 2025
Role of PRMT1 and PRMT5 in Breast Cancer.
Journal: International journal of molecular sciences
Published: July 10, 2024
Loss of G9a does not phenocopy the requirement for Prdm12 in the development of the nociceptive neuron lineage.
Journal: Neural development
Published: September 25, 2023
Neuroprotective effects of G9a inhibition through modulation of peroxisome-proliferator activator receptor gamma-dependent pathways by miR-128.
Journal: Neural regeneration research
Published: June 13, 2023
A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance.
Journal: Science advances
Published: March 15, 2023
PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer.
Journal: Life science alliance
Published: February 23, 2023
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer.
Journal: EMBO molecular medicine
Published: February 13, 2023
G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer's Disease.
Journal: Aging and disease
Published: January 22, 2023
Last Updated: 09/26/2026